Molly Stevens
FREng FRS
John Black Professor of Bionanoscience - Department of Physiology, Anatomy and Genetics and Institute of Biomedical Engineering
Professor Stevens joined the PSI in 2024, where she co-leads the diagnostics theme while also contributing to the development of next-generation vaccine formulations.
Professor Stevens’ multidisciplinary research balances the investigation of fundamental science with the development of technologies and designer biomaterials to address some of the major healthcare challenges across diagnostics, advanced therapeutics and regenerative medicine. Her research influences scientists around the world (>430 publications, h-index 121, >55k citations, consistently recognized as a Clarivate Highly Cited Researcher in the cross-field category for multiple years, including 2024). The impact of her work is recognised by over 30 accolades, including the 2023 Novo Nordisk Prize.
Professor Stevens’ work has a strong translational drive, focussed on translating scientific innovation into practical solutions to benefit patients and society. She is a serial entrepreneur and the founder of several spin-off companies in the diagnostics, advanced therapeutics, and regenerative medicine space.
Recent publications
Image-guided optimization of regenerative graft attachment to the heart
Journal article
Feng Z. et al, (2026), Biomaterials, 332, 124160 - 124160
Navigating Lipid Nanostructure Design Space Through Continuous Microfluidic Automation
Journal article
Diggines B. et al, (2026), Advanced Materials
Multistage microrobots with pH-responsive release of platelet membrane–coated nanoparticles
Journal article
Sun R. et al, (2026), Science Advances, 12
BODIPY Photocage‐Based Injectable Hydrogel for Light‐Controlled Nanoparticle Release
Journal article
Shao B. et al, (2026), Small, 22
A Dural Extracellular Matrix Hydrogel with Neural Stem Cells Improves Recovery from Traumatic Brain Injury in Mice.
Journal article
Lee-Reeves C. et al, (2026), ACS biomaterials science & engineering